新闻稿:Acaai:由Sanofi和再生元制药公司进行的Dupixent关键研究达成主要和次要评估标准,减轻过敏性真菌性鼻窦炎的症状...
新闻稿:Acaai:由Sanofi和再生元制药公司进行的Dupixent关键研究达成主要和次要评估标准,减轻过敏性真菌性鼻窦炎的症状...
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.